evolutio care innovations limited Company Information
Company Number
08099238
Next Accounts
Dec 2025
Shareholders
vsp global inc.
peter price-taylor
View AllGroup Structure
View All
Industry
Other human health activities
Registered Address
fora space thames tower, station road, reading, RG1 1LX
Website
www.evolutio-uk.comevolutio care innovations limited Estimated Valuation
Pomanda estimates the enterprise value of EVOLUTIO CARE INNOVATIONS LIMITED at £4.3m based on a Turnover of £6.6m and 0.64x industry multiple (adjusted for size and gross margin).
evolutio care innovations limited Estimated Valuation
Pomanda estimates the enterprise value of EVOLUTIO CARE INNOVATIONS LIMITED at £4.6m based on an EBITDA of £937.9k and a 4.9x industry multiple (adjusted for size and gross margin).
evolutio care innovations limited Estimated Valuation
Pomanda estimates the enterprise value of EVOLUTIO CARE INNOVATIONS LIMITED at £2m based on Net Assets of £796.8k and 2.49x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Evolutio Care Innovations Limited Overview
Evolutio Care Innovations Limited is a live company located in reading, RG1 1LX with a Companies House number of 08099238. It operates in the other human health activities sector, SIC Code 86900. Founded in June 2012, it's largest shareholder is vsp global inc. with a 33.9% stake. Evolutio Care Innovations Limited is a established, mid sized company, Pomanda has estimated its turnover at £6.6m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Evolutio Care Innovations Limited Health Check
Pomanda's financial health check has awarded Evolutio Care Innovations Limited a 4 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 3 areas for improvement. Company Health Check FAQs
4 Strong
4 Regular
3 Weak
Size
annual sales of £6.6m, make it larger than the average company (£730.1k)
- Evolutio Care Innovations Limited
£730.1k - Industry AVG
Growth
3 year (CAGR) sales growth of 8%, show it is growing at a similar rate (7.2%)
- Evolutio Care Innovations Limited
7.2% - Industry AVG
Production
with a gross margin of 38.3%, this company has a comparable cost of product (38.3%)
- Evolutio Care Innovations Limited
38.3% - Industry AVG
Profitability
an operating margin of 4.7% make it as profitable than the average company (5.1%)
- Evolutio Care Innovations Limited
5.1% - Industry AVG
Employees
with 89 employees, this is above the industry average (19)
89 - Evolutio Care Innovations Limited
19 - Industry AVG
Pay Structure
on an average salary of £26.5k, the company has an equivalent pay structure (£26.5k)
- Evolutio Care Innovations Limited
£26.5k - Industry AVG
Efficiency
resulting in sales per employee of £74.7k, this is more efficient (£45.5k)
- Evolutio Care Innovations Limited
£45.5k - Industry AVG
Debtor Days
it gets paid by customers after 38 days, this is later than average (20 days)
- Evolutio Care Innovations Limited
20 days - Industry AVG
Creditor Days
its suppliers are paid after 34 days, this is slower than average (18 days)
- Evolutio Care Innovations Limited
18 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Evolutio Care Innovations Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 6 weeks, this is less cash available to meet short term requirements (127 weeks)
6 weeks - Evolutio Care Innovations Limited
127 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 67.2%, this is a higher level of debt than the average (22%)
67.2% - Evolutio Care Innovations Limited
22% - Industry AVG
EVOLUTIO CARE INNOVATIONS LIMITED financials
Evolutio Care Innovations Limited's latest turnover from March 2024 is estimated at £6.6 million and the company has net assets of £796.8 thousand. According to their latest financial statements, Evolutio Care Innovations Limited has 89 employees and maintains cash reserves of £150.5 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | ||||||||||||
Other Income Or Grants | ||||||||||||
Cost Of Sales | ||||||||||||
Gross Profit | ||||||||||||
Admin Expenses | ||||||||||||
Operating Profit | ||||||||||||
Interest Payable | ||||||||||||
Interest Receivable | ||||||||||||
Pre-Tax Profit | ||||||||||||
Tax | ||||||||||||
Profit After Tax | ||||||||||||
Dividends Paid | ||||||||||||
Retained Profit | ||||||||||||
Employee Costs | ||||||||||||
Number Of Employees | 89 | 41 | 50 | 50 | 40 | 27 | ||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 504,258 | 611,880 | 561,218 | 469,266 | 455,044 | 297,882 | 208,949 | 241,903 | 129,863 | 23,917 | 30,285 | 0 |
Intangible Assets | 1,021,678 | 1,384,652 | 1,888,421 | 1,823,334 | 1,059,238 | 1,058,078 | 894,824 | 529,121 | 63,075 | 72,580 | 0 | 0 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 88 | 88 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 1,525,936 | 1,996,532 | 2,449,639 | 2,292,600 | 1,514,282 | 1,356,048 | 1,103,861 | 771,024 | 192,938 | 96,497 | 30,285 | 0 |
Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Debtors | 695,917 | 829,700 | 1,529,256 | 580,314 | 309,838 | 305,982 | 148,427 | 146,925 | 81,670 | 63,264 | 88,584 | 0 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 406,623 | 98,566 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 57,293 | 95,255 | 225,272 | 41,187 | 71,539 | 247,441 | 272,334 | 265,834 | 73,165 | 0 | 0 | 0 |
Cash | 150,465 | 19,629 | 388,894 | 318,360 | 633,140 | 400,461 | 582,235 | 286,670 | 16,322 | 28,747 | 22,363 | 0 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 903,675 | 944,584 | 2,143,422 | 939,861 | 1,014,517 | 1,360,507 | 1,101,562 | 699,429 | 171,157 | 92,011 | 110,947 | 0 |
total assets | 2,429,611 | 2,941,116 | 4,593,061 | 3,232,461 | 2,528,799 | 2,716,555 | 2,205,423 | 1,470,453 | 364,095 | 188,508 | 141,232 | 0 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 83,333 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 386,014 | 361,724 | 360,773 | 325,891 | 299,906 | 169,542 | 49,902 | 86,171 | 102,309 | 198,153 | 137,109 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 319,951 | 558,365 | 0 | 0 | 610 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 140,443 | 118,514 | 87,638 | 59,639 | 1,500 | 47,056 | 48,068 | 0 | 0 | 0 |
other current liabilities | 489,515 | 1,644,588 | 2,036,672 | 888,792 | 690,473 | 445,343 | 313,212 | 271,011 | 178,249 | 0 | 0 | 0 |
total current liabilities | 1,195,480 | 2,564,677 | 2,621,221 | 1,333,197 | 1,078,627 | 674,524 | 364,614 | 404,238 | 328,626 | 198,153 | 137,109 | 0 |
loans | 341,536 | 627,112 | 416,667 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 175,229 | 81,517 | 82,608 | 95,957 | 0 | 1,200 | 51,056 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 95,809 | 187,474 | 187,474 | 208,939 | 257,342 | 196,938 | 154,262 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 437,345 | 814,586 | 779,370 | 290,456 | 339,950 | 292,895 | 154,262 | 1,200 | 51,056 | 0 | 0 | 0 |
total liabilities | 1,632,825 | 3,379,263 | 3,400,591 | 1,623,653 | 1,418,577 | 967,419 | 518,876 | 405,438 | 379,682 | 198,153 | 137,109 | 0 |
net assets | 796,786 | -438,147 | 1,192,470 | 1,608,808 | 1,110,222 | 1,749,136 | 1,686,547 | 1,065,015 | -15,587 | -9,645 | 4,123 | 0 |
total shareholders funds | 796,786 | -438,147 | 1,192,470 | 1,608,808 | 1,110,222 | 1,749,136 | 1,686,547 | 1,065,015 | -15,587 | -9,645 | 4,123 | 0 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||||
Operating Profit | ||||||||||||
Depreciation | 262,341 | 27,358 | 321,775 | 27,396 | 116,507 | 81,723 | 58,484 | 18,450 | 16,799 | 8,895 | ||
Amortisation | 362,973 | 503,769 | 639,372 | 68,556 | 480,246 | 235,067 | 9,805 | 9,805 | 4,145 | 0 | ||
Tax | ||||||||||||
Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors | -171,745 | -829,573 | 1,133,027 | 240,124 | -578,669 | 440,719 | 106,568 | 257,924 | 91,571 | -25,320 | 88,584 | 0 |
Creditors | 24,290 | 951 | 34,882 | 25,985 | 130,364 | 119,640 | -36,269 | -16,138 | -95,844 | 61,044 | 137,109 | 0 |
Accruals and Deferred Income | -1,155,073 | -392,084 | 1,147,880 | 198,319 | 245,130 | 132,131 | 42,201 | 92,762 | 178,249 | 0 | 0 | 0 |
Deferred Taxes & Provisions | -91,665 | 0 | -21,465 | -48,403 | 60,404 | 42,676 | 154,262 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | ||||||||||||
Investing Activities | ||||||||||||
capital expenditure | ||||||||||||
Change in Investments | 0 | 0 | 0 | 0 | -88 | 0 | 88 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | ||||||||||||
Financing Activities | ||||||||||||
Bank loans | 0 | -83,333 | 83,333 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | -238,414 | 558,365 | 0 | -610 | 610 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | -285,576 | 210,445 | 416,667 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | -315,672 | 115,641 | 29,785 | 14,650 | 154,096 | -46,756 | -50,868 | 99,124 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | ||||||||||||
interest | ||||||||||||
cash flow from financing | ||||||||||||
cash and cash equivalents | ||||||||||||
cash | 130,836 | -369,265 | 70,534 | -314,780 | 232,679 | -181,774 | 295,565 | 270,348 | -12,425 | 6,384 | 22,363 | 0 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | 130,836 | -369,265 | 70,534 | -314,780 | 232,679 | -181,774 | 295,565 | 270,348 | -12,425 | 6,384 | 22,363 | 0 |
evolutio care innovations limited Credit Report and Business Information
Evolutio Care Innovations Limited Competitor Analysis
Perform a competitor analysis for evolutio care innovations limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other mid companies, companies in RG1 area or any other competitors across 12 key performance metrics.
evolutio care innovations limited Ownership
EVOLUTIO CARE INNOVATIONS LIMITED group structure
Evolutio Care Innovations Limited has 1 subsidiary company.
Ultimate parent company
EVOLUTIO CARE INNOVATIONS LIMITED
08099238
1 subsidiary
evolutio care innovations limited directors
Evolutio Care Innovations Limited currently has 6 directors. The longest serving directors include Mr Peter Price-Taylor (Jun 2012) and Mr Paul Heffernan (Jun 2014).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Peter Price-Taylor | England | 46 years | Jun 2012 | - | Director |
Mr Paul Heffernan | England | 58 years | Jun 2014 | - | Director |
Mr James Syrett | England | 43 years | Jun 2014 | - | Director |
Mr Simon Hardman-Lea | England | 67 years | Jul 2015 | - | Director |
Ms Melissa Sorenson | England | 49 years | Apr 2023 | - | Director |
Mr Vishal Sharma | England | 42 years | Apr 2023 | - | Director |
P&L
March 2024turnover
6.6m
+17%
operating profit
312.6k
0%
gross margin
38.4%
+2.26%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
796.8k
-2.82%
total assets
2.4m
-0.17%
cash
150.5k
+6.67%
net assets
Total assets minus all liabilities
evolutio care innovations limited company details
company number
08099238
Type
Private limited with Share Capital
industry
86900 - Other human health activities
incorporation date
June 2012
age
13
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
March 2024
previous names
N/A
accountant
WOODWHITE ACCOUNTANTS LTD
auditor
-
address
fora space thames tower, station road, reading, RG1 1LX
Bank
-
Legal Advisor
-
evolutio care innovations limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 2 charges/mortgages relating to evolutio care innovations limited. Currently there are 2 open charges and 0 have been satisfied in the past.
evolutio care innovations limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for EVOLUTIO CARE INNOVATIONS LIMITED. This can take several minutes, an email will notify you when this has completed.
evolutio care innovations limited Companies House Filings - See Documents
date | description | view/download |
---|